Exegi Pharma, LLC
Exegi Pharma, LLC
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial | High-Grade Squamous Intraepithelial Lesions, Morphological and Microscopic Findings, Pathological Conditions, Signs and Symptoms, Squamous Intraepithelial Lesions, human papillomavirus-related squamous cell carcinoma | Recruiting | Phase 2 | 2026-09-15 | NCT06949800 | |
| The Path Study: Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol, Transcutaneous Vagus Nerve Stimulation, and HIV Study | Cognition; Gut Microbiome | Recruiting | Not applicable | 2026-08-06 | NCT05090267 | |
| Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF) | Crohn ileitis, Digestive System Diseases, Ileal Diseases, digestive system disorder, enteritis, gastroenteritis, intestinal disorder, pouchitis | Recruiting | Phase 1 / Phase 2 | 2026-05-28 | NCT05938465 |